| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/24/2011 | WO2011022652A1 Topical gels |
| 02/24/2011 | WO2011022389A1 Compositions and methods for wound healing |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021892A2 Composition for skin improvement comprising hexamidines and retinoids |
| 02/24/2011 | WO2011021818A2 Composition for proliferating epidermal keratinocyte stem cells |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011020311A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
| 02/24/2011 | WO2011020167A1 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof |
| 02/24/2011 | WO2010147742A9 Use of nitrite salts in treating tissue damage |
| 02/24/2011 | WO2010129318A3 Topical compositions comprising an alkoxylated diphenylacrylate compound and an organic nonionic emulsifier |
| 02/24/2011 | WO2010128755A3 Composition for preventing or treating hair loss containing threonate as an active ingredient |
| 02/24/2011 | WO2010126260A9 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients |
| 02/24/2011 | WO2010123865A3 Two component interactive emulsion product |
| 02/24/2011 | WO2010111108A3 Compositions and methods for the treatment of wounds |
| 02/24/2011 | WO2010108488A4 Plant extracts for treating skin diseases |
| 02/24/2011 | WO2010007502A8 Platelet fraction deriving from placental blood |
| 02/24/2011 | US20110046532 composition including a silicone-based polymer and a method of treating skin disorders using the composition |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046225 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide |
| 02/24/2011 | US20110046223 Treatment of neurofibromatosis |
| 02/24/2011 | US20110046217 Use of 2,2'-cyclolignans for inducing, restoring or stimulating the pigmentation of the skin, hair or hairs |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046197 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 02/24/2011 | US20110046180 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046080 Composition for Treating a Skin Disorder |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110045983 Gel composition |
| 02/24/2011 | US20110045106 Coffee extract |
| 02/24/2011 | US20110045075 Tissue coating for preventing undesired tissue-to-tissue adhesions |
| 02/24/2011 | US20110045072 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
| 02/24/2011 | US20110045071 Generation of a novel type of anti-inflammatory macrophages for clinical use |
| 02/24/2011 | US20110045056 Hydrogel co-polymer composition and its uses, for example as a wound dressing |
| 02/24/2011 | US20110045047 Hemostatic implant |
| 02/24/2011 | US20110045041 Compositions and methods for the delivery of agents |
| 02/24/2011 | US20110045037 Foam containing benzoyl peroxide |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044964 Plant-based omega chewable supplement |
| 02/24/2011 | US20110044928 Microparticle film composition |
| 02/24/2011 | US20110044918 Novel sulfamide derivatives and cosmetic use thereof |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/24/2011 | CA2771308A1 Topical gels |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | CA2770162A1 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof |
| 02/24/2011 | CA2746459A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287290A2 Nestin-expressing hair follicle stem cells |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2286809A1 Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286669A1 Flavanones-containing food compositions |
| 02/23/2011 | EP2285775A1 Therapeutic lactams |
| 02/23/2011 | EP2285382A2 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 02/23/2011 | EP2285380A1 Methods for using tgf-b receptor inhibitors or activin-like kinase (alk) 5 inhibitors a-83-01 and sb-431542 to treat eye disease and wound healing conditions |
| 02/23/2011 | EP2285368A2 New Use |
| 02/23/2011 | EP2285367A1 Pharmaceutical compositions for the treatment of warts |
| 02/23/2011 | EP1765358B1 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 02/23/2011 | EP1634589B1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101980716A Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
| 02/23/2011 | CN101980709A Pyridazine derivatives and their use as therapeutic agents |
| 02/23/2011 | CN101980695A Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979088A Medicament for treating cauma and empyrosis |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979086A Chinese medicinal preparation for treating dermatophytosis |
| 02/23/2011 | CN101979065A Externally used Chinese medicinal liquor for treating eczema |
| 02/23/2011 | CN101979064A Traditional Chinese medicine for treating diabetic limb amputation |
| 02/23/2011 | CN101979063A Chinese medicament for treating diabetic foot |
| 02/23/2011 | CN101979059A Medicinal preparation for treating acne and preparation method thereof |
| 02/23/2011 | CN101979041A Chinese medicinal preparation for treating various dermatoses |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |